{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:35:22Z","timestamp":1792643722254,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12020-014-0521-6","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T02:02:24Z","timestamp":1420423344000},"page":"774-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire"],"prefix":"10.1007","volume":"49","author":[{"given":"Silvia","family":"Vandeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Yaneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Natchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanaska","family":"Elenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krasimir","family":"Kalinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Zacharieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,6]]},"reference":[{"issue":"1","key":"521_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93(1), 61\u201367 (2008). doi: 10.1210\/jc.2007-1191","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"521_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MED.0b013e32832cdec9","volume":"16","author":"A Santos","year":"2009","unstructured":"A. Santos, E. Resmini, M.A. Martinez, C. Marti, J. Ybarra, S.M. Webb, Quality of life in patients with pituitary tumors. Curr. Opin. Endocrinol. Diabetes Obes. 16(4), 299\u2013303 (2009). doi: 10.1097\/MED.0b013e32832cdec9","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"2","key":"521_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.02214","volume":"155","author":"SM Webb","year":"2006","unstructured":"S.M. Webb, X. Badia, N.L. Surinach, Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur. J. Endocrinol. 155(2), 269\u2013277 (2006). doi: 10.1530\/eje.1.02214","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"521_CR4","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"N.R. Biermasz, S.W. van Thiel, A.M. Pereira, H.C. Hoftijzer, A.M. van Hemert, J.W. Smit, J.A. Romijn, F. Roelfsema, Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J. Clin. Endocrinol. Metab. 89(11), 5369\u20135376 (2004). doi: 10.1210\/jc.2004-0669","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"521_CR5","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"S.V. Rowles, L. Prieto, X. Badia, S.M. Shalet, S.M. Webb, P.J. Trainer, Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J. Clin. Endocrinol. Metab. 90(6), 3337\u20133341 (2005). doi: 10.1210\/jc.2004-1565","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"521_CR6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02292","volume":"155","author":"SC Hua","year":"2006","unstructured":"S.C. Hua, Y.H. Yan, T.C. Chang, Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur. J. Endocrinol. 155(6), 831\u2013837 (2006). doi: 10.1530\/eje.1.02292","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"521_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-07-0356","volume":"157","author":"G T\u2019Sjoen","year":"2007","unstructured":"G. T\u2019Sjoen, M. Bex, D. Maiter, B. Velkeniers, R. Abs, Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. Eur. J. Endocrinol. 157(4), 411\u2013417 (2007). doi: 10.1530\/EJE-07-0356","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"521_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.2005.02307.x","volume":"63","author":"R Trepp","year":"2005","unstructured":"R. Trepp, R. Everts, C. Stettler, S. Fischli, S. Allemann, S.M. Webb, E.R. Christ, Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life questionnaire (AcroQoL). Clin. Endocrinol. (Oxf) 63(1), 103\u2013110 (2005). doi: 10.1111\/j.1365-2265.2005.02307.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"521_CR9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-07-0697","volume":"158","author":"MP Matta","year":"2008","unstructured":"M.P. Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, P. Caron, Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance. Eur. J. Endocrinol. 158(3), 305\u2013310 (2008). doi: 10.1530\/EJE-07-0697","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"521_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF03346555","volume":"33","author":"C Sardella","year":"2010","unstructured":"C. Sardella, M. Lombardi, G. Rossi, C. Cosci, S. Brogioni, I. Scattina, S.M. Webb, M. Gasperi, E. Martino, F. Bogazzi, Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J. Endocrinol. Invest. 33(1), 20\u201325 (2010)","journal-title":"J. Endocrinol. Invest."},{"key":"521_CR11","author":"H Kepicoglu","year":"2013","unstructured":"H. Kepicoglu, E. Hatipoglu, I. Bulut, E. Darici, N. Hizli, P. Kadioglu, Impact of treatment satisfaction on quality of life of patients with acromegaly. Pituitary (2013). doi: 10.1007\/s11102-013-0544-7","journal-title":"Pituitary"},{"issue":"5","key":"521_CR12","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jc.2004-2297","volume":"90","author":"NR Biermasz","year":"2005","unstructured":"N.R. Biermasz, A.M. Pereira, J.W. Smit, J.A. Romijn, F. Roelfsema, Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J. Clin. Endocrinol. Metab. 90(5), 2731\u20132739 (2005). doi: 10.1210\/jc.2004-2297","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"521_CR13","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","volume":"93","author":"SJ Neggers","year":"2008","unstructured":"S.J. Neggers, M.O. van Aken, W.W. de Herder, R.A. Feelders, J.A. Janssen, X. Badia, S.M. Webb, A.J. van der Lely, Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. J. Clin. Endocrinol. Metab. 93(10), 3853\u20133859 (2008). doi: 10.1210\/jc.2008-0669","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"521_CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1530\/EJE-11-0853","volume":"166","author":"MR Postma","year":"2012","unstructured":"M.R. Postma, R.T. Netea-Maier, G. van den Berg, J. Homan, W.J. Sluiter, M.A. Wagenmakers, A.C. van den Bergh, B.H. Wolffenbuttel, A.R. Hermus, A.P. van Beek, Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur. J. Endocrinol. 166(4), 585\u2013592 (2012). doi: 10.1530\/EJE-11-0853","journal-title":"Eur. J. Endocrinol."},{"key":"521_CR15","author":"R Mangupli","year":"2013","unstructured":"R. Mangupli, P. Camperos, S.M. Webb, Biochemical and quality of life responses to octreotide-LAR in acromegaly. Pituitary (2013). doi: 10.1007\/s11102-013-0533-x","journal-title":"Pituitary"},{"issue":"1","key":"521_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"A.A. van der Klaauw, N.R. Biermasz, H.C. Hoftijzer, A.M. Pereira, J.A. Romijn, Previous radiotherapy negatively influences quality of life during 4\u00a0years of follow-up in patients cured from acromegaly. Clin. Endocrinol. (Oxf) 69(1), 123\u2013128 (2008). doi: 10.1111\/j.1365-2265.2007.03169.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"521_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-013-0463-7","volume":"17","author":"E Hatipoglu","year":"2014","unstructured":"E. Hatipoglu, N. Topsakal, O.E. Atilgan, N. Alcalar, A.F. Camliguney, M. Niyazoglu, H.B. Cotuk, P. Kadioglu, Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary 17(1), 38\u201343 (2014). doi: 10.1007\/s11102-013-0463-7","journal-title":"Pituitary"},{"issue":"2","key":"521_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","volume":"57","author":"SM Webb","year":"2002","unstructured":"S.M. Webb, L. Prieto, X. Badia, M. Albareda, M. Catala, S. Gaztambide, T. Lucas, C. Paramo, A. Pico, A. Lucas, I. Halperin, G. Obiols, R. Astorga, Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. (Oxf) 57(2), 251\u2013258 (2002)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"521_CR19","first-page":"526","volume":"85","author":"A Giustina","year":"2000","unstructured":"A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85(2), 526\u2013529 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"521_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2265.2007.02703.x","volume":"66","author":"MC Sheppard","year":"2007","unstructured":"M.C. Sheppard, Growth hormone assay standardization: an important clinical advance. Clin. Endocrinol. (Oxf) 66(2), 157\u2013161 (2007). doi: 10.1111\/j.1365-2265.2007.02703.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"521_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","volume":"67","author":"AN Paisley","year":"2007","unstructured":"A.N. Paisley, S.V. Rowles, M.E. Roberts, S.M. Webb, X. Badia, L. Prieto, S.M. Shalet, P.J. Trainer, Treatment of acromegaly improves quality of life, measured by AcroQol. Clin. Endocrinol. (Oxf) 67(3), 358\u2013362 (2007). doi: 10.1111\/j.1365-2265.2007.02891.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"521_CR22","author":"P Anagnostis","year":"2014","unstructured":"P. Anagnostis, Z.A. Efstathiadou, M. Charizopoulou, D. Selalmatzidou, E. Karathanasi, M. Poulasouchidou, M. Kita, Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine (2014). doi: 10.1007\/s12020-014-0166-5","journal-title":"Endocrine"},{"issue":"3","key":"521_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ghir.2010.02.003","volume":"20","author":"MJ Wassenaar","year":"2010","unstructured":"M.J. Wassenaar, N.R. Biermasz, M. Kloppenburg, A.A. van der Klaauw, J. Tiemensma, J.W. Smit, A.M. Pereira, F. Roelfsema, H.M. Kroon, J.A. Romijn, Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res. 20(3), 226\u2013233 (2010). doi: 10.1016\/j.ghir.2010.02.003","journal-title":"Growth Horm IGF Res."},{"issue":"4","key":"521_CR24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.2004.05.186","volume":"22","author":"BJ Spiegler","year":"2004","unstructured":"B.J. Spiegler, E. Bouffet, M.L. Greenberg, J.T. Rutka, D.J. Mabbott, Change in neurocognitive functioning after treatment with cranial radiation in childhood. J. Clin. Oncol. 22(4), 706\u2013713 (2004). doi: 10.1200\/JCO.2004.05.186","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"521_CR25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-07-0838","volume":"158","author":"A Miller","year":"2008","unstructured":"A. Miller, H. Doll, J. David, J. Wass, Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur. J. Endocrinol. 158(5), 587\u2013593 (2008). doi: 10.1530\/EJE-07-0838","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"521_CR26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jc.2005-1616","volume":"91","author":"PJ Jenkins","year":"2006","unstructured":"P.J. Jenkins, P. Bates, M.N. Carson, P.M. Stewart, J.A. Wass, Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J. Clin. Endocrinol. Metab. 91(4), 1239\u20131245 (2006). doi: 10.1210\/jc.2005-1616","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"521_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-10-0969","volume":"164","author":"SJ Neggers","year":"2011","unstructured":"S.J. Neggers, J.J. Kopchick, J.O. Jorgensen, A.J. van der Lely, Hypothesis: extra-hepatic acromegaly: a new paradigm? Eur. J. Endocrinol. 164(1), 11\u201316 (2011). doi: 10.1530\/EJE-10-0969","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"521_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0030-1267912","volume":"119","author":"T Psaras","year":"2011","unstructured":"T. Psaras, J. Honegger, B. Gallwitz, M. Milian, Are there gender-specific differences concerning quality of life in treated acromegalic patients? Exp. Clin. Endocrinol. Diabetes 119(5), 300\u2013305 (2011). doi: 10.1055\/s-0030-1267912","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"521_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-6410-1-1","volume":"1","author":"AP Arnold","year":"2010","unstructured":"A.P. Arnold, Promoting the understanding of sex differences to enhance equity and excellence in biomedical science. Biol. Sex Differ. 1(1), 1 (2010). doi: 10.1186\/2042-6410-1-1","journal-title":"Biol. Sex Differ."},{"issue":"7","key":"521_CR30","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1210\/jc.2008-2671","volume":"94","author":"T Wexler","year":"2009","unstructured":"T. Wexler, L. Gunnell, Z. Omer, K. Kuhlthau, C. Beauregard, G. Graham, A.L. Utz, B. Biller, L. Nachtigall, J. Loeffler, B. Swearingen, A. Klibanski, K.K. Miller, Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J. Clin. Endocrinol. Metab. 94(7), 2471\u20132477 (2009). doi: 10.1210\/jc.2008-2671","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0521-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0521-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:57:07Z","timestamp":1559426227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0521-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0521-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,6]]}}}